Bisphenol AF Induces Hepatic Steatosis via Succinate–SUCNR1-Mediated Macrophage–Hepatocyte Interactions: An Adverse Outcome Pathway Study in Male C57BL/6 Mice
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26199720 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Ning Wang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Municipal Center for Disease Control and Prevention, Institute of Chemical Safety Evaluation/Key Laboratory of Environmental and Health Impa…. Hauptthemen laut MEDLINE: Fatty Liver, Phenols, Macrophages, Hepatocytes. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shanghai Natural Science Foundation, Shanghai Public Health Three-Year Action Plan.
Abstract (Originalsprache)
Bisphenol AF (BPAF) exposure is increasingly linked to metabolic disorders, yet the molecular initiating events (MIE) and key events (KE) leading to hepatic steatosis remain unclear. We constructed an adverse outcome pathway (AOP) to mechanistically connect BPAF-triggered macrophage–hepatocyte crosstalk to liver fat accumulation. Male C57BL/6 mice received daily oral gavage of 0, 0.5, 4, or 32 mg kg−1 BPAF for 90 d, and Transwell co-cultures of RAW264.7 macrophages and AML12 hepatocytes were used for in vitro validation. Targeted metabolomics, western blotting, and lipid staining quantified succinate, pathway proteins, and steatosis. BPAF dose-dependently increased serum succinate (BMD = 6901.95 nM) and hepatic triglyceride (TG) (BMD = 874.26 nM). Cryo-EM docking revealed BPAF binding to SUCNR1 at 2.9 Å, disrupting the inactive-state conformation. In co-culture, BPAF-exposed macrophages released succinate that bound hepatocyte SUCNR1, suppressed Akt phosphorylation, and activated JNK. These KEs led to a 40% increase in lipid droplets and elevated TG, total cholesterol (TC), and free fatty acids (FFA) without liver weight gain. We propose the first AOP for BPAF-induced hepatic steatosis: BPAF–SUCNR1 binding (MIE) → macrophage succinate release (KE1) → SUCNR1-mediated Akt inhibition/JNK activation (KE2–4) → hepatic lipid accumulation (KE5) → steatosis (AO). These findings provide mechanistic insight for chemical risk assessment of BPAF and structurally related bisphenols.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Shanghai Municipal Center for Disease Control and Prevention, Institute of Chemical Safety Evaluation/Key Laboratory of Environmental and Health Impact Assessment of New Pollutants, 1399 at Shenhong Road, Shanghai 20110…
ORCID-Profile: Ning Wang
Förderung
- Shanghai Natural Science Foundation
- Shanghai Public Health Three-Year Action Plan
Zitieren
APA
Wang, N., Leng, J., Zhang, H., Xu, J., Yu, X., Qian, K., Zheng, Z., Ying, M., Tao, G., Xiao, P., & Hong, X. (2025). Bisphenol AF Induces Hepatic Steatosis via Succinate–SUCNR1-Mediated Macrophage–Hepatocyte Interactions: An Adverse Outcome Pathway Study in Male C57BL/6 Mice. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26199720
Vancouver
Wang N, Leng J, Zhang H, Xu J, Yu X, Qian K, et al. Bisphenol AF Induces Hepatic Steatosis via Succinate–SUCNR1-Mediated Macrophage–Hepatocyte Interactions: An Adverse Outcome Pathway Study in Male C57BL/6 Mice. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26199720
BibTeX
@article{Wang2025,
author = {Wang, Ning and Leng, Jing and Zhang, Huimin and Xu, Jing and Yu, Xiaoqi and Qian, Kelei and Zheng, Zhiqing and Ying, Mengchao and Tao, Gonghua and Xiao, Ping and Hong, Xinyu},
title = {Bisphenol AF Induces Hepatic Steatosis via Succinate–SUCNR1-Mediated Macrophage–Hepatocyte Interactions: An Adverse Outcome Pathway Study in Male C57BL/6 Mice},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26199720}
}
EUVIMED